1
|
Oueslati S, Serairi Beji R, Zar Kalai F, Soufiani M, Zorrig W, Aissam S, Msaada K, El Modafar C. Antioxidant potentialities and gastroprotective effect of Reichardia picroides extracts on Ethanol/HCl induced gastric ulcer rats. INTERNATIONAL JOURNAL OF ENVIRONMENTAL HEALTH RESEARCH 2024; 34:1088-1099. [PMID: 37015007 DOI: 10.1080/09603123.2023.2198760] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/05/2023] [Accepted: 03/29/2023] [Indexed: 06/19/2023]
Abstract
The goal of this study was to determine for the first time the polyphenol content, antioxidant, and gastroprotective properties of the roots and leaves of Reichardia picroides. TPC considerably varied as a function of organs and solvent nature and ranged from 50 to 284.80 mg GAE/g DW. Leaves exhibited the highest amount of phenolics by using acetone 70%, the same tendency was observed for antioxidant activity. Besides, in vivo gastro-protective effects following HCl/EtOH-induced ulcer models displayed that roots extract at a high dose (500 mg) seemed to be the best performing extract with a decrease of ulceration index (UI) and an increase in the percentage of protection (PP), SOD, CAT, and GPX activities. All these data have been proved with principal component analysis (PCA). Overall, the results indicated that R. picroides could be considered a valuable source of natural compounds, which are beneficial for human health.
Collapse
Affiliation(s)
- Samia Oueslati
- Laboratory of Extremophile Plants, Centre of Biotechnology of Borj Cedria, Hammam-Lif, Tunisia
| | - Raja Serairi Beji
- Laboratory of Aromatic and Medicinal Plants, Centre of Biotechnology of Borj Cedria, Hammam-Lif, Tunisia
- Department of Nutrition, High School of Health Sciences and Technics, Tunis, Tunisia
| | - Feten Zar Kalai
- Laboratory of Aromatic and Medicinal Plants, Centre of Biotechnology of Borj Cedria, Hammam-Lif, Tunisia
| | - Merieme Soufiani
- Laboratory of Biotechnology and Molecular Bioengineering, Department of Biology, Faculty of Sciences and Techniques Guéliz, Cadi Ayyad University, Marrakech, Morocco
| | - Walid Zorrig
- Laboratory of Extremophile Plants, Centre of Biotechnology of Borj Cedria, Hammam-Lif, Tunisia
| | - Salama Aissam
- Laboratory of Biotechnology and Molecular Bioengineering, Department of Biology, Faculty of Sciences and Techniques Guéliz, Cadi Ayyad University, Marrakech, Morocco
| | - Kamel Msaada
- Laboratory of Aromatic and Medicinal Plants, Centre of Biotechnology of Borj Cedria, Hammam-Lif, Tunisia
| | - Cherkaoui El Modafar
- Laboratory of Biotechnology and Molecular Bioengineering, Department of Biology, Faculty of Sciences and Techniques Guéliz, Cadi Ayyad University, Marrakech, Morocco
| |
Collapse
|
2
|
Meurer M, Felisbino F, Müller FB, Somensi LB, Cury BJ, Jerônimo DT, Venzon L, França TCS, Mariott M, Santos AC, Nunes RKS, Boeing T, Bella-Cruz A, Souza PDE, Roman-Junior WA, Arunachalam K, Oliveira RG, Silva LM. Antiulcer mechanisms of the hydroalcoholic extract from Aztec marigolds' medicinal and edible flowers (Tagetes erecta L.). AN ACAD BRAS CIENC 2023; 95:e20220427. [PMID: 37556712 DOI: 10.1590/0001-3765202320220427] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2022] [Accepted: 09/15/2022] [Indexed: 08/11/2023] Open
Abstract
The antiulcer mechanisms of the dry extract of T. erecta flowers (DETe) were studied here. The acute ulcers induced by acidified ethanol or indomethacin were reproduced in mice pretreated with DETe (3 - 300 mg/kg). The antiulcer activity of DETe was also verified in mice pretreated with NEM, L-NAME, indomethacin, or yohimbine. The antisecretory effect of DETe was verified in rats, and its anti-Helicobacter pylori activity was determined in vitro. DETe (300 mg/kg, p.o) reduced the ethanol- or indomethacin-induced ulcer by 49 and 93%, respectively. The pre-treatment with L-NAME, NEM or yohimbine abolished the gastroprotective effect of DETe. However, DETe did not change the volume, acidity, or peptic activity in rats and did not affect H. pylori. This study expands knowledge about the antiulcerogenic potential of DETe, evidencing the role of nitric oxide, non-protein sulfhydryl groups, α2 adrenergic receptors, and prostaglandins, but not antisecretory or anti-H. pylori properties.
Collapse
Affiliation(s)
- Mariane Meurer
- Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade do Vale do Itajaí, Núcleo de Pesquisas Farmacêuticas Químicas (NIQFAR), Rua Uruguai, 458, Centro, 89809-900 Itajaí, SC, Brazil
| | - Fabiula Felisbino
- Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade do Vale do Itajaí, Núcleo de Pesquisas Farmacêuticas Químicas (NIQFAR), Rua Uruguai, 458, Centro, 89809-900 Itajaí, SC, Brazil
| | - Fabiana B Müller
- Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade do Vale do Itajaí, Núcleo de Pesquisas Farmacêuticas Químicas (NIQFAR), Rua Uruguai, 458, Centro, 89809-900 Itajaí, SC, Brazil
| | - Lincon B Somensi
- Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade do Vale do Itajaí, Núcleo de Pesquisas Farmacêuticas Químicas (NIQFAR), Rua Uruguai, 458, Centro, 89809-900 Itajaí, SC, Brazil
- Programa de Pós-Graduação em Desenvolvimento e Sociedade, Universidade Alto Vale do Rio do Peixe, Rua Victor Baptista Adami, 800, Centro, 89500-000 Caçador, SC, Brazil
| | - Benhur J Cury
- Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade do Vale do Itajaí, Núcleo de Pesquisas Farmacêuticas Químicas (NIQFAR), Rua Uruguai, 458, Centro, 89809-900 Itajaí, SC, Brazil
| | - Daniele T Jerônimo
- Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade do Vale do Itajaí, Núcleo de Pesquisas Farmacêuticas Químicas (NIQFAR), Rua Uruguai, 458, Centro, 89809-900 Itajaí, SC, Brazil
| | - Larissa Venzon
- Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade do Vale do Itajaí, Núcleo de Pesquisas Farmacêuticas Químicas (NIQFAR), Rua Uruguai, 458, Centro, 89809-900 Itajaí, SC, Brazil
| | - Tauani C S França
- Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade do Vale do Itajaí, Núcleo de Pesquisas Farmacêuticas Químicas (NIQFAR), Rua Uruguai, 458, Centro, 89809-900 Itajaí, SC, Brazil
| | - Marihá Mariott
- Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade do Vale do Itajaí, Núcleo de Pesquisas Farmacêuticas Químicas (NIQFAR), Rua Uruguai, 458, Centro, 89809-900 Itajaí, SC, Brazil
| | - Ana C Santos
- Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade do Vale do Itajaí, Núcleo de Pesquisas Farmacêuticas Químicas (NIQFAR), Rua Uruguai, 458, Centro, 89809-900 Itajaí, SC, Brazil
| | - Ruan Kaio S Nunes
- Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade do Vale do Itajaí, Núcleo de Pesquisas Farmacêuticas Químicas (NIQFAR), Rua Uruguai, 458, Centro, 89809-900 Itajaí, SC, Brazil
| | - Thaise Boeing
- Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade do Vale do Itajaí, Núcleo de Pesquisas Farmacêuticas Químicas (NIQFAR), Rua Uruguai, 458, Centro, 89809-900 Itajaí, SC, Brazil
| | - Alexandre Bella-Cruz
- Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade do Vale do Itajaí, Núcleo de Pesquisas Farmacêuticas Químicas (NIQFAR), Rua Uruguai, 458, Centro, 89809-900 Itajaí, SC, Brazil
| | - Priscila DE Souza
- Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade do Vale do Itajaí, Núcleo de Pesquisas Farmacêuticas Químicas (NIQFAR), Rua Uruguai, 458, Centro, 89809-900 Itajaí, SC, Brazil
| | - Walter A Roman-Junior
- Programa de Pós-Graduação em Ciências da Saúde, Universidade Comunitária da Região de Chapecó, Servidão Anjo da Guarda, 295-D, Efapi, 89809-900 Chapecó, SC, Brazil
| | - Karuppusamy Arunachalam
- Chinese Academy of Sciences, Kunming Institute of Botany, Key Laboratory of Economic Plants and Biotechnology and the Yunnan Key Laboratory for Wild Plant Resources, Kunming 650201, People's Republic of China
| | - Ruberlei G Oliveira
- Universidade Federal de Mato Grosso, Escola de Educação Física (Programa de Pós-Graduação), Avenida Universitária, 3500, Parque Universitário, 78060-900 Cuiabá, MT, Brazil
| | - Luisa M Silva
- Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade do Vale do Itajaí, Núcleo de Pesquisas Farmacêuticas Químicas (NIQFAR), Rua Uruguai, 458, Centro, 89809-900 Itajaí, SC, Brazil
| |
Collapse
|
3
|
Aldana-Mejía JA, de Miranda AM, Ccana-Ccapatinta GV, de Araújo LS, Ribeiro VP, Arruda C, Nascimento S, Squarisi I, Esperandim T, de Freitas KS, Ozelin SD, Tavares DC, Ramalho FS, Bastos JK. Genotoxicity and toxicological evaluations of Brazilian red propolis oral ingestion in a preclinical rodent model. JOURNAL OF ETHNOPHARMACOLOGY 2023; 303:115920. [PMID: 36372194 DOI: 10.1016/j.jep.2022.115920] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/16/2022] [Revised: 10/29/2022] [Accepted: 11/06/2022] [Indexed: 06/16/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Brazilian red propolis is a natural product known due to its medicinal properties. The efficacy of this natural resin has been proved; however, few studies report the safety of its oral use. Some toxic effects of natural products may not be expressed in traditional use, and preclinical studies are necessary to guarantee their safety. Health regulatory agency currently requires these non-clinical studies to develop drugs and herbal medicines, including genotoxic and oral toxicity tests. AIM OF THE STUDY Accomplish the preclinical toxicity studies of Brazilian red propolis extract (BRP) in rodents, including genotoxicity, acute and sub-chronic toxicities. MATERIAL AND METHODS Genotoxicity assays followed the erythrocyte micronucleus test protocol in a range of 500-2000 mg/kg BRP oral treatment on male Swiss mice. After an up-and-down procedure, acute oral toxicity (single dose) was performed on female Wistar Hannover rats, reaching a 2000 mg/kg BRP oral gavage concentration. Animals were monitored periodically until 14 days and euthanized for a macroscopic necropsy analysis. The sub-chronic oral toxicity test (90 days) was achieved with 1000 mg/kg of BRP on Wistar Hannover rats (males/females). Animals were monitored to evaluated behavioral and biometrical changes, then were euthanized to perfomed hematological, biochemical, and histopathological analyses. RESULTS No genotoxic effect of the BRP was detected. The acute toxicity indicated no toxicity of a single oral dose of 2000 mg/kg of BRP. The long-term oral toxicity performed with 1000 mg/kg of BRP altered water and food intake and the biometrics, hematological and biochemical parameters. Biochemical alterations in hepatic and renal parameters were detected only in the males. Despite the detection of biochemical alterations, no histopathological changes were detected in the organs of any group. CONCLUSIONS BRP, at a higher dose, showed no signs of immediate toxicity. However, the obtained results suggest that the chemical composition and the intake of higher doses deserve special attention regarding possible toxicity.
Collapse
Affiliation(s)
- Jennyfer Andrea Aldana-Mejía
- School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Avenida do Café, s/nº, Ribeirão Preto, São Paulo, Brazil.
| | - Aline Mayrink de Miranda
- School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Avenida do Café, s/nº, Ribeirão Preto, São Paulo, Brazil.
| | - Gari Vidal Ccana-Ccapatinta
- School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Avenida do Café, s/nº, Ribeirão Preto, São Paulo, Brazil.
| | - Luciana Silva de Araújo
- School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Avenida do Café, s/nº, Ribeirão Preto, São Paulo, Brazil.
| | - Victor Pena Ribeiro
- School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Avenida do Café, s/nº, Ribeirão Preto, São Paulo, Brazil.
| | - Caroline Arruda
- School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Avenida do Café, s/nº, Ribeirão Preto, São Paulo, Brazil.
| | - Samuel Nascimento
- Nucleus of Research in Sciences and Technology, Laboratory of Mutagenesis, University of Franca, Av. Dr. Armando de Sáles Oliveira, 201 - Parque Universitario, Franca, São Paulo, Brazil.
| | - Iara Squarisi
- Nucleus of Research in Sciences and Technology, Laboratory of Mutagenesis, University of Franca, Av. Dr. Armando de Sáles Oliveira, 201 - Parque Universitario, Franca, São Paulo, Brazil.
| | - Tábata Esperandim
- Nucleus of Research in Sciences and Technology, Laboratory of Mutagenesis, University of Franca, Av. Dr. Armando de Sáles Oliveira, 201 - Parque Universitario, Franca, São Paulo, Brazil.
| | - Karoline S de Freitas
- Nucleus of Research in Sciences and Technology, Laboratory of Mutagenesis, University of Franca, Av. Dr. Armando de Sáles Oliveira, 201 - Parque Universitario, Franca, São Paulo, Brazil.
| | - Saulo D Ozelin
- Nucleus of Research in Sciences and Technology, Laboratory of Mutagenesis, University of Franca, Av. Dr. Armando de Sáles Oliveira, 201 - Parque Universitario, Franca, São Paulo, Brazil.
| | - Denise Crispim Tavares
- Nucleus of Research in Sciences and Technology, Laboratory of Mutagenesis, University of Franca, Av. Dr. Armando de Sáles Oliveira, 201 - Parque Universitario, Franca, São Paulo, Brazil.
| | - Fernando Silva Ramalho
- Department of Pathology, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Av. Bandeirantes, 3900, Ribeirão Preto, São Paulo, Brazil.
| | - Jairo Kenupp Bastos
- School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Avenida do Café, s/nº, Ribeirão Preto, São Paulo, Brazil.
| |
Collapse
|
4
|
Boeing T, Monteiro Magalhães de Oliveira B, Aldana-Mejía JA, Vidal Ccana-Ccapatinta G, Venzon L, Judah Cury B, Santos França TC, de Souza P, Roman Junior WA, Mota da Silva L, Kenupp Bastos J. Brazilian Red Propolis Accelerates Gastric Healing and Reduces Gastric Submucosal Layer Inflammation in Ultrasound-Monitored Rats. Chem Biodivers 2023; 20:e202200992. [PMID: 36445831 DOI: 10.1002/cbdv.202200992] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2022] [Revised: 11/28/2022] [Accepted: 11/29/2022] [Indexed: 11/30/2022]
Abstract
Propolis has been used for the treatment of gastric disturbances in folk medicine, nevertheless, the gastric healing effects of Brazilian red propolis have not been unveiled. This study aimed to assess the gastric healing effect of the hydroalcoholic extract of red propolis (HERP) in the acetic acid-induced ulcer model. Rats under acetic acid-induced-ulcer were treated with HERP (100 mg/kg, p.o.) twice a day for seven days. Histological changes, oxidative stress, and inflammatory parameters were analyzed in the gastric tissue. Moreover, the gastric wall thickness was measured by ultrasound. The in vitro cytotoxicity of HERP and cellular migration of fibroblasts were evaluated. The treatment with HERP promoted gastric healing, reducing gastric wall thickness, macroscopic lesion area, and histopathological damages compared to the vehicle. Moreover, HERP reduced oxidative stress and inflammation in the gastric tissue but did not change mucin or collagen levels. HERP did not show signs of toxicity either in vivo or in vitro. HERP displayed a healing effect in vivo by reducing oxidative stress and inflammation. These data contribute to validating the popular use of this product in the treatment of gastric disorders and advance scientific knowledge in the search for new drugs for the management of gastric ulcers.
Collapse
Affiliation(s)
- Thaise Boeing
- Postgraduate Program in Pharmaceutical Sciences (PPGCF), Universidade do Vale do Itajaí (UNIVALI), Itajaí, Santa Catarina, Brazil
| | | | - Jennyfer Andrea Aldana-Mejía
- School of Pharmaceutical Sciences of Ribeirão Preto, Universidade de São Paulo (USP), Ribeirão Preto, São Paulo, Brazil
| | - Gari Vidal Ccana-Ccapatinta
- School of Pharmaceutical Sciences of Ribeirão Preto, Universidade de São Paulo (USP), Ribeirão Preto, São Paulo, Brazil
| | - Larissa Venzon
- Postgraduate Program in Pharmaceutical Sciences (PPGCF), Universidade do Vale do Itajaí (UNIVALI), Itajaí, Santa Catarina, Brazil
| | - Benhur Judah Cury
- Postgraduate Program in Pharmaceutical Sciences (PPGCF), Universidade do Vale do Itajaí (UNIVALI), Itajaí, Santa Catarina, Brazil
| | - Tauani Caroline Santos França
- Postgraduate Program in Pharmaceutical Sciences (PPGCF), Universidade do Vale do Itajaí (UNIVALI), Itajaí, Santa Catarina, Brazil
| | - Priscila de Souza
- Postgraduate Program in Pharmaceutical Sciences (PPGCF), Universidade do Vale do Itajaí (UNIVALI), Itajaí, Santa Catarina, Brazil
| | - Walter Antônio Roman Junior
- Postgraduate Program in Health Sciences, Universidade Comunitária da região de Chapecó (UNOCHAPECÓ), Chapecó, Santa Catarina, Brazil
| | - Luísa Mota da Silva
- Postgraduate Program in Pharmaceutical Sciences (PPGCF), Universidade do Vale do Itajaí (UNIVALI), Itajaí, Santa Catarina, Brazil
| | - Jairo Kenupp Bastos
- School of Pharmaceutical Sciences of Ribeirão Preto, Universidade de São Paulo (USP), Ribeirão Preto, São Paulo, Brazil
| |
Collapse
|
5
|
Potential in vitro anti-periodontopathogenic, anti-Chikungunya activities and in vivo toxicity of Brazilian red propolis. Sci Rep 2022; 12:21165. [PMID: 36477635 PMCID: PMC9729292 DOI: 10.1038/s41598-022-24776-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2022] [Accepted: 11/21/2022] [Indexed: 12/12/2022] Open
Abstract
Bacterial and viral infections are serious public health issue. Therefore, this study aimed to evaluate the antibacterial, antibiofilm and antiviral potential of the Brazilian Red Propolis (BRP) crude hydroalcoholic extract, fractions, and isolated compounds, as well as their in vivo toxicity. The antibacterial activity was evaluated by determining the Minimum Inhibitory Concentration and the antibiofilm activity by determining the Minimum Inhibitory Concentration of Biofilm (MICB50). The viable bacteria count (Log10 UFC/mL) was also obtained. The antiviral assays were performed by infecting BHK-21 cells with Chikungunya (CHIKV) nanoluc. The toxicity of the BRP was evaluated in the Caenorhabditis elegans animal model. The MIC values for the crude hydroalcoholic extract sample ranged from 3.12 to 100 μg/mL, while fractions and isolated compounds the MIC values ranged from 1.56 to 400 μg/mL.The BRP crude hydroalcoholic extract, oblongifolin B, and gutiferone E presented MICB50 values ranging from 1.56 to 100 μg/mL against monospecies and multispecies biofilms. Neovestitol and vestitol inhibited CHIKV infection by 93.5 and 96.7%, respectively. The tests to evaluate toxicity in C. elegans demonstrated that the BRP was not toxic below the concentrations 750 μg/mL. The results constitute an alternative approach for treating various infectious diseases.
Collapse
|
6
|
Neto NFDO, Bonvicini JFS, de Souza GL, Santiago MB, Veneziani RCS, Ambrósio SR, Bastos JK, Silva MJB, Martins CHG, Moura CCG, Turrioni AP. Antibacterial activity of Brazilian red propolis and in vitro evaluation of free radical production. Arch Oral Biol 2022; 143:105520. [PMID: 36049430 DOI: 10.1016/j.archoralbio.2022.105520] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2022] [Revised: 08/07/2022] [Accepted: 08/08/2022] [Indexed: 12/31/2022]
Abstract
OBJECTIVE This study aimed to evaluate the antibacterial activity of crude Brazilian red propolis (BRP) extract against anaerobic bacteria involved in primary endodontic infection. Additionally, we evaluate the cell viability and free radical production of human dental pulp fibroblasts (HDPF) in direct contact with mineral trioxide aggregate (MTA) and BRP. DESIGN The Minimum Inhibitory Concentration, Minimum Bactericidal Concentration (MIC, MBC) and Minimum Inhibitory Concentration of Biofilm (MICB50) of BRP against anaerobic endodontic pathogens were determined. HDPF were exposed to BRP10 (10 μg/mL), BRP50 (50 μg/mL), MTA extract (1:1, 1:2, 1:4 e 1:8), dimethyl sulfoxide 0.5% (DMSO), and cell culture medium (DMEM). The groups were tested for cell viability (MTT assay), and free radical production (reactive oxygen species - ROS, DCFH-DA probe and nitric oxide - NO, Griess reagent). The one-way ANOVA and Tukey's tests were employed at a significance level of 5%. RESULTS MIC/MBC values of BRP performed antibacterial activity for Parvimonas micra (6.25/6.25 µg/mL), Fusobacterium nucleatum (25/25 µg/mL), Prevotella melaninogenica (50/100 µg/mL), Prevotella nigrescens (50/100 µg/mL), Prevotella intermedia (50/100 µg/mL), and Porphyromonas gingivalis (50/200 µg/mL). The MICB50 values ranged from 1.56 to 50 μg/mL. BRP and MTA stimulated cell viability, emphasizing BRP10 (p = 0.007). Furthermore, it was observed that MTA 1:1, MTA 1:2, and BRP50 slightly increased ROS (p < 0.001) and NO production (p = 0.008, p = 0.007, and p < 0.001 respectively) compared to DMEM group. CONCLUSIONS BRP exhibits good antibacterial activity against endodontic pathogens, and both BRP and MTA promote the viability of HDPF without increasing NO and ROS production.
Collapse
Affiliation(s)
| | | | - Gabriela Leite de Souza
- Department of Endodontics, School of Dentistry, Federal University of Uberlândia, Minas Gerais, Brazil.
| | - Mariana Brentini Santiago
- Laboratory of Antimicrobial Testing, Institute of Biomedical Sciences, Federal University of Uberlândia, Minas Gerais, Brazil.
| | | | | | - Jairo Kenupp Bastos
- Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
| | - Marcelo José Barbosa Silva
- Laboratory of Tumor Biomarkers and Osteoimmunology, Institute of Biomedical Sciences, Federal University of Uberlândia, Minas Gerais, Brazil.
| | - Carlos Henrique Gomes Martins
- Laboratory of Antimicrobial Testing, Institute of Biomedical Sciences, Federal University of Uberlândia, Minas Gerais, Brazil.
| | | | - Ana Paula Turrioni
- Department of Pediatric Dentistry, School of Dentistry, Federal University of Uberlândia, Minas Gerais, Brazil.
| |
Collapse
|
7
|
Santiago MB, Leandro LF, Rosa RB, Silva MV, Teixeira SC, Servato JPS, Ambrósio SR, Veneziani RCS, Aldana-Mejía JA, Bastos JK, Martins CHG. Brazilian Red Propolis Presents Promising Anti- H. pylori Activity in In Vitro and In Vivo Assays with the Ability to Modulate the Immune Response. Molecules 2022; 27:7310. [PMID: 36364137 PMCID: PMC9658018 DOI: 10.3390/molecules27217310] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2022] [Revised: 10/17/2022] [Accepted: 10/20/2022] [Indexed: 10/01/2023] Open
Abstract
Helicobacter pylori is a Gram-negative, microaerophilic, curved-rod, flagellated bacterium commonly found in the stomach mucosa and associated with different gastrointestinal diseases. With high levels of prevalence worldwide, it has developed resistance to the antibiotics used in its therapy. Brazilian red propolis has been studied due to its biological properties, and in the literature, it has shown promising antibacterial activities. The aim of this study was to evaluate anti-H. pylori from the crude hydroalcoholic extract of Brazilian red propolis (CHEBRP). For this, in vitro determination of the minimum inhibitory and bactericidal concentration (MIC/MBC) and synergistic activity and in vivo, microbiological, and histopathological analyses using Wistar rats were carried out using CHEBRP against H. pylori strains (ATCC 46523 and clinical isolate). CHEBRP presented MIC/MBC of 50 and 100 μg/mL against H. pylori strains (ATCC 43526 and clinical isolate, respectively) and tetracycline MIC/MBC of 0.74 µg/mL. The association of CHEBRP with tetracycline had an indifferent effect. In the stomach mucosa of rats, all treatments performed significantly decreased the number of H. pylori, and a concentration of 300 mg/kg was able to modulate the inflammatory response in the tissue. Therefore, CHEBRP showed promising anti-H. pylori in in vitro and in vivo assays.
Collapse
Affiliation(s)
- Mariana B. Santiago
- Laboratory of Antimicrobial Testing, Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia 38405318, MG, Brazil
| | - Luis Fernando Leandro
- Laboratory of Antimicrobial Testing, Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia 38405318, MG, Brazil
| | - Rafael B. Rosa
- Complex of Animal Facilities, Federal University of Uberlândia, Uberlândia 38405315, MG, Brazil
| | - Murilo V. Silva
- Complex of Animal Facilities, Federal University of Uberlândia, Uberlândia 38405315, MG, Brazil
| | - Samuel C. Teixeira
- Laboratory of Antimicrobial Testing, Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia 38405318, MG, Brazil
| | | | - Sérgio Ricardo Ambrósio
- Nucleus of Research in Sciences and Technolog, University of Franca, Franca 14404600, SP, Brazil
| | | | - Jennyfer A. Aldana-Mejía
- Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14040900, SP, Brazil
| | - Jairo K. Bastos
- Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14040900, SP, Brazil
| | - Carlos Henrique G. Martins
- Laboratory of Antimicrobial Testing, Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia 38405318, MG, Brazil
| |
Collapse
|
8
|
Hossain R, Quispe C, Khan RA, Saikat ASM, Ray P, Ongalbek D, Yeskaliyeva B, Jain D, Smeriglio A, Trombetta D, Kiani R, Kobarfard F, Mojgani N, Saffarian P, Ayatollahi SA, Sarkar C, Islam MT, Keriman D, Uçar A, Martorell M, Sureda A, Pintus G, Butnariu M, Sharifi-Rad J, Cho WC. Propolis: An update on its chemistry and pharmacological applications. Chin Med 2022; 17:100. [PMID: 36028892 PMCID: PMC9412804 DOI: 10.1186/s13020-022-00651-2] [Citation(s) in RCA: 17] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2022] [Accepted: 08/02/2022] [Indexed: 12/23/2022] Open
Abstract
Propolis, a resinous substance produced by honeybees from various plant sources, has been used for thousands of years in traditional medicine for several purposes all over the world. The precise composition of propolis varies according to plant source, seasons harvesting, geography, type of bee flora, climate changes, and honeybee species at the site of collection. This apiary product has broad clinical applications such as antioxidant, anti-inflammatory, antimicrobial, anticancer, analgesic, antidepressant, and anxiolytic as well asimmunomodulatory effects. It is also well known from traditional uses in treating purulent disorders, improving the wound healing, and alleviating many of the related discomforts. Even if its use was already widespread since ancient times, after the First and Second World War, it has grown even more as well as the studies to identify its chemical and pharmacological features, allowing to discriminate the qualities of propolis in terms of the chemical profile and relative biological activity based on the geographic place of origin. Recently, several in vitro and in vivo studies have been carried out and new insights into the pharmaceutical prospects of this bee product in the management of different disorders, have been highlighted. Specifically, the available literature confirms the efficacy of propolis and its bioactive compounds in the reduction of cancer progression, inhibition of bacterial and viral infections as well as mitigation of parasitic-related symptoms, paving the way to the use of propolis as an alternative approach to improve the human health. However, a more conscious use of propolis in terms of standardized extracts as well as new clinical studies are needed to substantiate these health claims.
Collapse
Affiliation(s)
- Rajib Hossain
- Department of Pharmacy, Life Science Faculty, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, Dhaka, 8100, Bangladesh
| | - Cristina Quispe
- Facultad de Ciencias de La Salud, Universidad Arturo Prat, Avda. Arturo Prat 2120, 1110939, Iquique, Chile
| | - Rasel Ahmed Khan
- Pharmacy Discipline, Life Science School, Khulna University, Khulna, 9280, Bangladesh
| | - Abu Saim Mohammad Saikat
- Department of Biochemistry and Molecular Biology, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, 8100, Bangladesh
| | - Pranta Ray
- Department of Biomedical Engineering, Huazhong University of Science and Technology, Wuhan, China
| | - Damira Ongalbek
- Faculty of Chemistry and Chemical Technology, Al-Farabi Kazakh National University, 050040, Almaty, Kazakhstan
| | - Balakyz Yeskaliyeva
- Faculty of Chemistry and Chemical Technology, Al-Farabi Kazakh National University, 050040, Almaty, Kazakhstan
| | - Divya Jain
- Department of Bioscience and Biotechnology, Banasthali Vidyapith, Rajasthan, 304022, India
| | - Antonella Smeriglio
- Department of Chemical, Biological, Pharmaceutical and Environmental Sciences (ChiBioFarAm), University of Messina, Viale Ferdinando Stagno d'Alcontres 31, 98166, Messina, Italy.
| | - Domenico Trombetta
- Department of Chemical, Biological, Pharmaceutical and Environmental Sciences (ChiBioFarAm), University of Messina, Viale Ferdinando Stagno d'Alcontres 31, 98166, Messina, Italy
| | - Roghayeh Kiani
- Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
| | - Farzad Kobarfard
- Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.,Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Naheed Mojgani
- Department of Biotechnology, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran
| | - Parvaneh Saffarian
- Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran
| | - Seyed Abdulmajid Ayatollahi
- Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.,Department of Pharmacognosy and Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Chandan Sarkar
- Department of Pharmacy, Life Science Faculty, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, Dhaka, 8100, Bangladesh
| | - Mohammad Torequl Islam
- Department of Pharmacy, Life Science Faculty, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, Dhaka, 8100, Bangladesh
| | - Dılhun Keriman
- Food Processing Department, Vocational School of Technical Sciences, Bingöl University, Bingöl, Turkey
| | - Arserim Uçar
- Food Processing Department, Vocational School of Technical Sciences, Bingöl University, Bingöl, Turkey.
| | - Miquel Martorell
- Department of Nutrition and Dietetics, Faculty of Pharmacy, and Centre for Healthy Living, University of Concepción, Concepción, Chile. .,Universidad de Concepción, Unidad de Desarrollo Tecnológico, UDT, 4070386, Concepción, Chile.
| | - Antoni Sureda
- Research Group on Community Nutrition and Oxidative Stress, Laboratory of Physical Activity Sciences, and CIBEROBN - Physiopathology of Obesity and Nutrition, CB12/03/30038, University of Balearic Islands, Palma, Spain
| | - Gianfranco Pintus
- Department of Medical Laboratory Sciences, College of Health Sciences and Sharjah Institute for Medical Research, University of Sharjah, 22272, Sharjah, United Arab Emirates.,Department of Biomedical Sciences, University of Sassari, 07100, Sassari, Italy
| | - Monica Butnariu
- Chemistry & Biochemistry Discipline, University of Life Sciences King Mihai I from Timisoara, Calea Aradului 119, 300645, Timis, Romania
| | - Javad Sharifi-Rad
- Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
| | - William C Cho
- Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong.
| |
Collapse
|
9
|
Molecular Insights into the Antistress Potentials of Brazilian Green Propolis Extract and Its Constituent Artepillin C. Molecules 2021; 27:molecules27010080. [PMID: 35011307 PMCID: PMC8746355 DOI: 10.3390/molecules27010080] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2021] [Revised: 12/13/2021] [Accepted: 12/16/2021] [Indexed: 11/25/2022] Open
Abstract
Propolis, also known as bee-glue, is a resinous substance produced by honeybees from materials collected from plants they visit. It contains mixtures of wax and bee enzymes and is used by bees as a building material in their hives and by humans for different purposes in traditional healthcare practices. Although the composition of propolis has been shown to depend on its geographic location, climatic zone, and local flora; two largely studied types of propolis: (i) New Zealand and (ii) Brazilian green propolis have been shown to possess Caffeic Acid Phenethyl Ester (CAPE) and Artepillin C (ARC) as the main bioactive constituents, respectively. We have earlier reported that CAPE and ARC possess anticancer activities, mediated by abrogation of mortalin-p53 complex and reactivation of p53 tumor suppressor function. Like CAPE, Artepillin C (ARC) and the supercritical extract of green propolis (GPSE) showed potent anticancer activity. In this study, we recruited low doses of GPSE and ARC (that did not affect either cancer cell proliferation or migration) to investigate their antistress potential using in vitro cell based assays. We report that both GPSE and ARC have the capability to disaggregate metal- and heat-induced aggregated proteins. Metal-induced aggregation of GFP was reduced by fourfold in GPSE- as well as ARC-treated cells. Similarly, whereas heat-induced misfolding of luciferase protein showed 80% loss of activity, the cells treated with either GPSE or ARC showed 60–80% recovery. Furthermore, we demonstrate their pro-hypoxia (marked by the upregulation of HIF-1α) and neuro-differentiation (marked by differentiation morphology and upregulation of expression of GFAP, β-tubulin III, and MAP2). Both GPSE and ARC also offered significant protection against oxidative stress and, hence, may be useful in the treatment of old age-related brain pathologies.
Collapse
|
10
|
Ruiz-Hurtado PA, Garduño-Siciliano L, Domínguez-Verano P, Balderas-Cordero D, Gorgua-Jiménez G, Canales-Álvarez O, Canales-Martínez MM, Rodríguez-Monroy MA. Propolis and Its Gastroprotective Effects on NSAID-Induced Gastric Ulcer Disease: A Systematic Review. Nutrients 2021; 13:nu13093169. [PMID: 34579045 PMCID: PMC8466107 DOI: 10.3390/nu13093169] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2021] [Revised: 09/07/2021] [Accepted: 09/09/2021] [Indexed: 02/07/2023] Open
Abstract
Gastric ulcer disease induced by the consumption of NSAIDs is a major public health problem. The therapy used for its treatment causes adverse effects in the patient. Propolis is a natural product that has been used for the treatments of different diseases around the world. Nevertheless, there is little information about the activity of propolis in gastric ulcers caused by treatment with NSAIDs. Therefore, this review evaluates and compares the gastroprotective potential of propolis and its function against NSAID-induced gastric ulcers, for which a systematic search was carried out in the PubMed and ScienceDirect databases. The main criteria were articles that report the gastroprotective activity of propolis against the damage produced by NSAIDs in the gastric mucosa. Gastroprotection was related to the antioxidant, antisecretory, and cytoprotective effects, as well as the phenolic compounds present in the chemical composition of propolis. However, most of the studies used different doses of NSAIDs and propolis and evaluated different parameters. Propolis has proven to be a good alternative for the treatment of gastric ulcer disease. However, future studies should be carried out to identify the compounds responsible for these effects and to determine their potential use in people.
Collapse
Affiliation(s)
- Porfirio Alonso Ruiz-Hurtado
- Laboratorio de Toxicología de Productos Naturales, Departamento de Farmacia, Instituto Politécnico Nacional, Escuela Nacional de Ciencias Biológicas, Av. Wilfrido Massieu, Gustavo A. Madero, Ciudad de México 07738, Mexico; (P.A.R.-H.); (L.G.-S.)
- Laboratorio de Investigación Biomédica en Productos Naturales, Carrera de Medicina, UNAM, FES-Iztacala, Avenida de los Barrios Número 1, Colonia Los Reyes Iztacala, Estado de México 54090, Mexico; (P.D.-V.); (D.B.-C.); (G.G.-J.); (O.C.-Á.)
| | - Leticia Garduño-Siciliano
- Laboratorio de Toxicología de Productos Naturales, Departamento de Farmacia, Instituto Politécnico Nacional, Escuela Nacional de Ciencias Biológicas, Av. Wilfrido Massieu, Gustavo A. Madero, Ciudad de México 07738, Mexico; (P.A.R.-H.); (L.G.-S.)
| | - Pilar Domínguez-Verano
- Laboratorio de Investigación Biomédica en Productos Naturales, Carrera de Medicina, UNAM, FES-Iztacala, Avenida de los Barrios Número 1, Colonia Los Reyes Iztacala, Estado de México 54090, Mexico; (P.D.-V.); (D.B.-C.); (G.G.-J.); (O.C.-Á.)
| | - Daniela Balderas-Cordero
- Laboratorio de Investigación Biomédica en Productos Naturales, Carrera de Medicina, UNAM, FES-Iztacala, Avenida de los Barrios Número 1, Colonia Los Reyes Iztacala, Estado de México 54090, Mexico; (P.D.-V.); (D.B.-C.); (G.G.-J.); (O.C.-Á.)
| | - Gustavo Gorgua-Jiménez
- Laboratorio de Investigación Biomédica en Productos Naturales, Carrera de Medicina, UNAM, FES-Iztacala, Avenida de los Barrios Número 1, Colonia Los Reyes Iztacala, Estado de México 54090, Mexico; (P.D.-V.); (D.B.-C.); (G.G.-J.); (O.C.-Á.)
- Laboratorio de Genética, Departamento de Farmacia, Instituto Politécnico Nacional, Escuela Nacional de Ciencias Biológicas, Av. Wilfrido Massieu, Gustavo A. Madero, Ciudad de México 07738, Mexico
| | - Octavio Canales-Álvarez
- Laboratorio de Investigación Biomédica en Productos Naturales, Carrera de Medicina, UNAM, FES-Iztacala, Avenida de los Barrios Número 1, Colonia Los Reyes Iztacala, Estado de México 54090, Mexico; (P.D.-V.); (D.B.-C.); (G.G.-J.); (O.C.-Á.)
- Laboratorio de Genética, Departamento de Farmacia, Instituto Politécnico Nacional, Escuela Nacional de Ciencias Biológicas, Av. Wilfrido Massieu, Gustavo A. Madero, Ciudad de México 07738, Mexico
| | - María Margarita Canales-Martínez
- Laboratorio de Farmacognosia, UBIPRO, UNAM, FES-Iztacala, Avenida de los Barrios Número 1, Colonia Los Reyes Iztacala, Estado de México 54090, Mexico;
| | - Marco Aurelio Rodríguez-Monroy
- Laboratorio de Investigación Biomédica en Productos Naturales, Carrera de Medicina, UNAM, FES-Iztacala, Avenida de los Barrios Número 1, Colonia Los Reyes Iztacala, Estado de México 54090, Mexico; (P.D.-V.); (D.B.-C.); (G.G.-J.); (O.C.-Á.)
- Correspondence: ; Tel.: +52-5545-205-185
| |
Collapse
|